Vital Therapies Revenue and Competitors
Estimated Revenue & Valuation
- Vital Therapies's estimated annual revenue is currently $7.8M per year. 0
- Vital Therapies's total funding is $228.4M.
Employee Data
- 00
Vital Therapies's People
| Name | Title | Email/Phone |
|---|
Vital Therapies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Vital Therapies?
Vital Therapies, Inc. (VTI) is a new company formed in 2003 to continue the development of the ELAD® (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient’s liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix.
keywords:N/A
$228.4M
Total Funding
N/A
Number of Employees
$7.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vital Therapies News
Vital therapies for cancer patients and their families are to resume following a two year hiatus. Clan Cancer Support is reopening seven centres...
Families forced to fundraise for vital therapies as a recent reconfiguration of services into Children's Disability Network Teams has made...
Autoimmune Disease Diagnostics Market Know-How Industry to Experience Positive Growth | Karate Health, Inc, Vital Therapies, Inc.,...
San Diego-based Vital Therapies has filed for an IPO, saying in a filing late Friday that it is looking to raised $86.25M in an IPO effort on the NASDAQ Global Market. The company is looking to trade as VTL. The company, which develops cell-based treatments for acute liver failure, is backed by ...
Fifteen investors backed development-stage biotechnology company Vital Therapies in a $22.5 million funding round to support the company’s ongoing ELAD research & development program manufacturing bio-artificial livers based on human cells. The San Diego, Calif.-based company, which was founded ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $40.9M | 0 | N/A | $11.9M |
#2 | $48.8M | 0 | N/A | $31.6M |
#3 | $13.9M | 0 | N/A | $35M |
#4 | $22.4M | 0 | N/A | $3.7M |
#5 | $1850M | 0 | N/A | N/A |